STRO Sutro Biopharma Inc.

10.7
-0.18  -2%
Previous Close 10.88
Open 10.87
Price To Book 2.05
Market Cap 245,328,134
Shares 22,927,863
Volume 105,310
Short Ratio
Av. Daily Volume 49,453

NewsSee all news

  1. Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 4, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ:STRO) today announced that Bill Newell, CEO of Sutro Biopharma, will present a corporate overview at the H.C. Wainwright 21st

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 initial efficacy data due YE 2019.
STRO-001
Non-Hodgkin lymphoma (NHL)
Phase 1 initial data due YE 2019.
STRO-002
Ovarian and Endometrial Cancer

Latest News

  1. Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 4, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ:STRO) today announced that Bill Newell, CEO of Sutro Biopharma, will present a corporate overview at the H.C. Wainwright 21st